For further details see:
TG, OVID, FCEL and MESO among after-hours moversFor further details see:
TG, OVID, FCEL and MESO among after-hours moversMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-04-04 18:15:03 ET Wedbush analyst issues OUTPERFORM recommendation for OVID on April 4, 2024 04:19PM ET. OVID was trading at $3.05 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company dedicated to meaningfully improvi...
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in a virtual presentation at t...